A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

GSK Investigational Site, Dublin

GSK Investigational Site, Dublin

GSK Investigational Site, Dublin

GSK Investigational Site, Dublin

GSK Investigational Site, Westmead

GSK Investigational Site, Miskolc

GSK Investigational Site, Debrecen

GSK Investigational Site, Southport

GSK Investigational Site, Adelaide

GSK Investigational Site, Nedlands

GSK Investigational Site, Pécs

GSK Investigational Site, New York

GSK Investigational Site, Marseille

GSK Investigational Site, Genoa

GSK Investigational Site, Rozzano (MI)

GSK Investigational Site, Kiel

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Hanover

GSK Investigational Site, Pamplona

GSK Investigational Site, Orlando

GSK Investigational Site, Bordeaux

GSK Investigational Site, Udine

GSK Investigational Site, Kassel

GSK Investigational Site, Padua

GSK Investigational Site, Birmingham

GSK Investigational Site, Mobile

GSK Investigational Site, Magdeburg

GSK Investigational Site, Seville

GSK Investigational Site, Modena

GSK Investigational Site, Essen

GSK Investigational Site, Indianapolis

GSK Investigational Site, Ann Arbor

GSK Investigational Site, Münster

GSK Investigational Site, Cologne

GSK Investigational Site, Reims

GSK Investigational Site, Siena

GSK Investigational Site, Bonn

GSK Investigational Site, Mainz

GSK Investigational Site, Koblenz

GSK Investigational Site, Lille

GSK Investigational Site, Wiesbaden

GSK Investigational Site, Homburg

GSK Investigational Site, Ludwigshafen am Rhein

GSK Investigational Site, Heidelberg

GSK Investigational Site, Paris

GSK Investigational Site, Paris

GSK Investigational Site, Ulm

GSK Investigational Site, Los Angeles

GSK Investigational Site, Nuremberg

GSK Investigational Site, Erlangen

GSK Investigational Site, La Jolla

GSK Investigational Site, Regensburg

GSK Investigational Site, San Francisco

GSK Investigational Site, Vallejo

GSK Investigational Site, Villejuif

GSK Investigational Site, Erfurt

GSK Investigational Site, Moscow

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Stavropol

GSK Investigational Site, Ryazan

GSK Investigational Site, Kazan'

GSK Investigational Site, Lebanon

GSK Investigational Site, Edmonton

GSK Investigational Site, Kelowna

GSK Investigational Site, Toronto

GSK Investigational Site, Toronto

GSK Investigational Site, Montreal

GSK Investigational Site, Nice

GSK Investigational Site, Gera

GSK Investigational Site, Jena

GSK Investigational Site, Budapest

GSK Investigational Site, Győr

GSK Investigational Site, Cork

GSK Investigational Site, Galway

GSK Investigational Site, Rome

GSK Investigational Site, Rome

GSK Investigational Site, Terni

GSK Investigational Site, Amsterdam

GSK Investigational Site, Brzozów

GSK Investigational Site, Konin

GSK Investigational Site, Krakow

GSK Investigational Site, Słupsk

GSK Investigational Site, Warsaw

GSK Investigational Site, Badalona

GSK Investigational Site, Barcelona

GSK Investigational Site, Barcelona

GSK Investigational Site, Hospitalet de Llobregat, Barcelona